Brief: Spimaco Signs Term Sheet With Jiangsu Recbio Technology On HPV Vaccines

Jiangsu Recbio Technology

23/01/2024 05:23

Jan 23 (Reuters) - SAUDI PHARMACEUTICAL INDUSTRIES AND
MEDICAL APPLIANCES CORPORATION  2070.SE :
    * ANNOUNCES SIGNING OF A TERM SHEET (NON-BINDING) WITH
JIANGSU
RECBIO TECHNOLOGY CO. ON HPV VACCINES
    * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO IMPORT HPV IN
FINISHED PRODUCT FORM,
    * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO 
COMMERCIALIZE AND
DISTRIBUTE RECBIO’S HPV VACCINE IN THE KINGDOM AND THE WIDER
MENA REGION
    * SPIMACO WILL RECEIVE AN EXCLUSIVE LICENSE TO LOCALIZE
PRODUCTION
OF HPV IN BULK FORMAT FOLLOWING CONCLUSION OF TECHNOLOGY
TRANSFER
    * MEMORANDUM DURATION 1 YEAR FROM DATE OF SIGNING

Further company coverage:  2070.SE 

 ((Reuters.Briefs@thomsonreuters.com;))